{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:21:19Z","timestamp":1773822079078,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012709","name":"National University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012709","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020552","name":"Oman Ministry of Higher Education Research and Innovation","doi-asserted-by":"publisher","award":["BFP\/RGP\/CBS\/23\/337"],"award-info":[{"award-number":["BFP\/RGP\/CBS\/23\/337"]}],"id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118381","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:50:00Z","timestamp":1763646600000},"page":"118381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["The therapeutic potential of scaffold containing substituted amine derivatives in the drug design of antidepressant compounds"],"prefix":"10.1016","volume":"302","author":[{"given":"Namy","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9460-5304","authenticated-orcid":false,"given":"Md Jawaid","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Al Balushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushara","family":"Al Sabahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shah Alam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118381_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2012.11.042","article-title":"Antidepressant and antipsychotic activity of new quinoline-and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A\/5-HT2A\/5-HT7 and dopamine D2\/D3 receptors","volume":"60","author":"Zajdel","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2020.101331","article-title":"Schiff base ligand L synthesis and its evaluation as anticancer and antidepressant agent","volume":"33","author":"Sadia","year":"2021","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.ejmech.2025.118381_bib3","unstructured":"Depressive disorder (depression), https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression, (31 March 2023)."},{"key":"10.1016\/j.ejmech.2025.118381_bib4","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1016\/j.bmcl.2010.09.085","article-title":"5-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl] ethyl}-2 (1H)-quinolinones and 3, 4-dihydro-2 (1H)-quinolinones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3","volume":"20","author":"Bromidge","year":"2010","journal-title":"Biorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118381_bib5","article-title":"Profiling the antidepressant properties of phenyl piperidine derivatives as inhibitors of serotonin transporter (SERT) via cheminformatics modeling, molecular docking and ADMET predictions","volume":"9","author":"Olasupo","year":"2020","journal-title":"Sci. Afr."},{"key":"10.1016\/j.ejmech.2025.118381_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.arabjc.2013.08.027","article-title":"Synthesis, characterization and screening for antidepressant and anticonvulsant activity of 4, 5-dihydropyrazole bearing indole derivatives","volume":"9","author":"Patil","year":"2016","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0975-7406.80765","article-title":"Antidepressant potential of nitrogen-containing heterocyclic moieties: an updated review","volume":"3","author":"Siddiqui","year":"2011","journal-title":"J. Pharm. BioAllied Sci."},{"key":"10.1016\/j.ejmech.2025.118381_bib8","article-title":"Bifidobacteria with indole-3-lactic acid-producing capacity exhibit psychobiotic potential via reducing neuroinflammation","volume":"5","author":"Qian","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejmech.2025.118381_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroimage.2013.10.002","article-title":"Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET","volume":"88","author":"Baldinger","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejmech.2025.118381_bib10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.bmc.2011.12.039","article-title":"Quinoline-and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor\u20145-HT1A\/5-HT2A\/5-HT7 and D2\/D3\/D4\u2014agents: the synthesis and pharmacological evaluation","volume":"20","author":"Zajdel","year":"2012","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.11.040","article-title":"Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy) ethyl-alkyl amines: multiobjective based design, synthesis, and antidepressant and anxiolytic properties","volume":"108","author":"Canale","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejmech.2014.03.066","article-title":"Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl) phenyl] piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor","volume":"79","author":"Hansen","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126703","article-title":"Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"29","author":"Gu","year":"2019","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.dcmed.2020.06.003","article-title":"Acts as an antidepressant by promoting synaptic function in the hippocampal neurons","volume":"3","author":"Zi-Rong","year":"2020","journal-title":"Digital Chinese Medicine"},{"key":"10.1016\/j.ejmech.2025.118381_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2008.10.055","article-title":"Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system","volume":"602","author":"Posser","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118381_bib16","doi-asserted-by":"crossref","first-page":"27657","DOI":"10.1039\/D4RA04730C","article-title":"FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 years","volume":"14","author":"Bindra","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118381_bib17","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1016\/j.bmcl.2014.09.050","article-title":"Synthesis and structure\u2013activity relationship of novel cinnamamide derivatives as antidepressant agents","volume":"24","author":"Han","year":"2014","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104371","article-title":"Novel mechanisms underlying rapid-acting antidepressants: ketamine-like compounds, neurosteroid GABAkines, and psychedelics","author":"Castanheira","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118381_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N, N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2025.118381_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/02791072.1994.10472600","article-title":"Psychedelic and entactogenic drugs in the treatment of depression","volume":"26","author":"Riedlinger","year":"1994","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.ejmech.2025.118381_bib21","doi-asserted-by":"crossref","first-page":"27657","DOI":"10.1039\/D4RA04730C","article-title":"FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 years","volume":"14","author":"Bindra","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118381_bib22","series-title":"Comprehensive Clinical Psychology","first-page":"135","article-title":"6.06 - psychopharmacology","author":"Cowen","year":"1998"},{"key":"10.1016\/j.ejmech.2025.118381_bib23","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.cellsig.2014.04.022","article-title":"Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications","volume":"26","author":"Yin","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2025.118381_bib24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/brainsci12101329","article-title":"Targeting NMDA receptors in emotional disorders: their role in neuroprotection","volume":"12","author":"Wang","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejmech.2025.118381_bib25","first-page":"283","article-title":"13 activation mechanisms of the nmda receptor","author":"Blanke","year":"2008","journal-title":"Biol. NMDA Recept."},{"key":"10.1016\/j.ejmech.2025.118381_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.fct.2019.03.004","article-title":"Immunoregulatory natural compounds in stress-induced depression: an alternative or an adjunct to conventional antidepressant therapy?","volume":"127","author":"Vasileva","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2025.118381_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118381_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.554899","article-title":"A systematic review of efficacy, safety, and tolerability of duloxetine","volume":"11","author":"Rodrigues-Amorim","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.118381_bib29","doi-asserted-by":"crossref","first-page":"137S","DOI":"10.1212\/WNL.47.6_Suppl_3.137S","article-title":"Pharmacology of selegiline","volume":"47","author":"Gerlach","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2025.118381_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109348","article-title":"Antidepressants in the post-ketamine era: pharmacological approaches targeting the glutamatergic system","volume":"223","author":"Chaki","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118381_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118381_bib32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/pharmrev.120.000149","article-title":"Hydroxynorketamines: pharmacology and potential therapeutic applications","volume":"73","author":"Jaclyn N Highland","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.118381_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/a-1714-9097","article-title":"Novel antidepressants in the pipeline (phase II and III): a systematic review of the US clinical trials registry","volume":"55","author":"Sakurai","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejmech.2025.118381_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.9740\/mhc.2019.03.076","article-title":"Evaluation of dextromethorphan with select antidepressant therapy for the treatment of depression in the acute care psychiatric setting","volume":"9","author":"Nofziger","year":"2019","journal-title":"Mental Health Clinician"},{"key":"10.1016\/j.ejmech.2025.118381_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12955-020-01599-3","article-title":"The effect of methadone on depression among addicts: a systematic review and meta-analysis","volume":"18","author":"Mohammadi","year":"2020","journal-title":"Health Qual. Life Outcome"},{"key":"10.1016\/j.ejmech.2025.118381_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.euroneuro.2014.11.010","article-title":"The pharmacodynamic properties of lurasidone and their role in its antidepressant efficacy in bipolar disorder","volume":"25","author":"Fountoulakis","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2025.118381_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/ph18020157","article-title":"Demystifying the antidepressant mechanism of action of Stinels, a novel class of Neuroplastogens: positive allosteric modulators of the NMDA receptor","volume":"18","author":"Donello","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118381_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/medicina61040558","article-title":"Pharmacological monotherapy for depressive disorders: current and future\u2014A narrative review","volume":"61","author":"Gao","year":"2025","journal-title":"Medicina"},{"key":"10.1016\/j.ejmech.2025.118381_bib39","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12928","article-title":"A phase 2, randomized, double-blind, placebo-controlled study of adjunctive pimavanserin in patients with major depressive disorder and an inadequate response to therapy (CLARITY)","volume":"80","author":"Fava","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.118381_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.64719\/pb.4448","article-title":"Adjunctive pimavanserin in patients with major depressive disorder: combined results from two randomized, double-blind, placebo-controlled phase 3 studies","volume":"52","author":"Dirks","year":"2022","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ejmech.2025.118381_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109690","article-title":"The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: a focus on human neurological and neuropsychiatric diseases","volume":"239","author":"Zhou","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118381_bib42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1021\/acs.jmedchem.3c01225","article-title":"Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders","volume":"67","author":"Raithatha","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib43","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.118381_bib44","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.3110-06.2007","article-title":"Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation","volume":"27","author":"Svenningsson","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118381_bib45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.neuropharm.2010.12.006","article-title":"A microdialysis study of ST1936, a novel 5-HT6 receptor agonist","volume":"60","author":"Valentini","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118381_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbr.2011.05.019","article-title":"Effects of the 5-HT6 receptor agonist ST 1936 on depression-and anhedonia-like experimental models","volume":"224","author":"Scheggi","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2025.118381_bib47","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1016\/j.bmcl.2016.05.061","article-title":"Design, synthesis and biological evaluation of novel chiral oxazino-indoles as potential and selective neuroprotective agents against A\u03b225\u201335-induced neuronal damage","volume":"26","author":"Chen","year":"2016","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/np070371u","article-title":"Secondary metabolites from three Florida sponges with antidepressant activity","volume":"71","author":"Kochanowska","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118381_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/md15080248","article-title":"Marine inspired 2-(5-Halo-1 H-indol-3-yl)-N, N-dimethylethanamines as modulators of serotonin receptors: an example illustrating the power of bromine as part of the uniquely marine chemical space","volume":"15","author":"Ibrahim","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2025.118381_bib50","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.bmc.2013.02.010","article-title":"Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists\u2013serotonin reuptake transporter inhibitors for the treatment of depression","volume":"21","author":"Wu","year":"2013","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bmc.2016.10.034","article-title":"Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT1A weak partial agonistic activity showing the antidepressant-like effect","volume":"25","author":"Yoshinaga","year":"2017","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129006","article-title":"Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI\/5-HT1A","volume":"76","author":"Yuan","year":"2022","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.compbiolchem.2016.12.004","article-title":"A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK1R antagonists\/serotonin transporter (SERT) inhibitors","volume":"67","author":"Zare","year":"2017","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejmech.2012.04.030","article-title":"Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors","volume":"54","author":"Zheng","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126769","article-title":"Synthesis and antidepressant-like activity of novel alkoxy-piperidine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"29","author":"Wang","year":"2019","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111736","article-title":"Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl) pyrrolidine-2, 5-dione derivatives with potential antidepressant effect","volume":"183","author":"Wr\u00f3bel","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib57","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1016\/j.arabjc.2020.03.009","article-title":"Synthesis and pharmacological evaluation of 3-[5-(aryl-[1, 3, 4] oxadiazole-2-yl]-piperidine derivatives as anticonvulsant and antidepressant agents","volume":"13","author":"Singh","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115139","article-title":"Novel potent blockers for TWIK-1\/TREK-1 heterodimers as potential antidepressants","volume":"165","author":"Lee","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118381_bib59","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1016\/j.bmcl.2007.05.012","article-title":"4-Phenyl-4-[1H-imidazole-2-yl]-piperidine derivatives as non-peptidic selective \u03b4-opioid agonists with potential anxiolytic\/antidepressant properties. Part 2","volume":"17","author":"Trabanco","year":"2007","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib60","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2016.08.037","article-title":"New piperidine-hydrazone derivatives: synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors","volume":"124","author":"Karaman","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib61","first-page":"14","article-title":"Design, synthesis and characterization of novel 6, 7-dimethoxy-N 2-(substituted benzyl)-N 2-propylquinazoline-2, 4-diamine derivatives as anxiolytic and antidepressant agents","volume":"3","author":"Srivastav","year":"2013","journal-title":"Am. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116601","article-title":"Dual 5-HT6\/SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-\u03b2 toxicity, memory preservation, and antidepressant-like properties","volume":"275","author":"Siwek","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106031","article-title":"Development of indole-2-carbonyl piperazine urea derivatives as selective FAAH inhibitors for efficient treatment of depression and pain","volume":"128","author":"Shang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117698","article-title":"Design, synthesis, and biological evaluation of aralkyl piperazine and piperidine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"104","author":"Wu","year":"2024","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib65","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1016\/j.bmc.2017.04.046","article-title":"The impact of the halogen bonding on D2 and 5-HT1A\/5-HT7 receptor activity of azinesulfonamides of 4-[(2-ethyl) piperidinyl-1-yl] phenylpiperazines with antipsychotic and antidepressant properties","volume":"25","author":"Partyka","year":"2017","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib66","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1021\/acs.jmedchem.8b01183","article-title":"Synthesis, receptor affinity, and antiallodynic activity of spirocyclic \u03c3 receptor ligands with exocyclic amino moiety","volume":"61","author":"Bergkemper","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib67","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.bmc.2017.03.057","article-title":"Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy) propyl piperidines: add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile","volume":"25","author":"Canale","year":"2017","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib68","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/jhet.4617","article-title":"Chalcones: versatile intermediates in heterocyclic synthesis","volume":"60","author":"Nayak","year":"2023","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib69","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.1039\/D5RA01929J","article-title":"Exploring N-heterocyclic linked novel hybrid chalcone derivatives: synthesis, characterization, evaluation of antidepressant activity, toxicity assessment, molecular docking, DFT and ADME study","volume":"15","author":"Deshmukh","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118381_bib70","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s11030-021-10374-5","article-title":"Design, synthesis, and computational studies of phenylacetamides as antidepressant agents","volume":"26","author":"Suryawanshi","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.118381_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100610","article-title":"Design, synthesis, and biological activity of chalcone analogs containing 4\u2010phenylquinolin and benzohydrazide","volume":"19","author":"Tan","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.118381_bib72","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1016\/j.bmcl.2012.09.089","article-title":"Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues","volume":"22","author":"Prashanth","year":"2012","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117941","article-title":"Synthesis and biological evaluation of novel isobenzofuran-1 (3H)-one derivatives as antidepressant agents","volume":"114","author":"Tao","year":"2024","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118381_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127176","article-title":"Discovery of \u03b4 opioid receptor full agonists lacking a basic nitrogen atom and their antidepressant-like effects","volume":"30","author":"Fujii","year":"2020","journal-title":"Biorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118381_bib75","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.bmc.2011.04.002","article-title":"Design, synthesis and pharmacological evaluation of spirocyclic \u03c31 receptor ligands with exocyclic amino moiety (increased distance 1)","volume":"19","author":"Rack","year":"2011","journal-title":"Biorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:20:21Z","timestamp":1773818421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":75,"alternative-id":["S0223523425011468"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118381","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of scaffold containing substituted amine derivatives in the drug design of antidepressant compounds","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118381"}}